Michael has spent the last seventeen years in biotechnology building, leading and motivating process development and manufacturing teams to support clinical programs from early development to late stage clinical trials.
Michael has been responsible for process development and analytics, cGMP manufacturing operations, CMC regulatory strategy, cellular procurement, and process characterization and validation activities for multiple novel viral, cell and gene therapy products. Currently, Michael is the Sr. Vice President of CMC Operations at Elevatebio leading the process development, manufacturing and CMC regulatory for a broad portfolio of gene and cell therapy products. Prior to Elevatebio, Michael was the Vice President of CMC operations at Oncorus working on the development of a next-generation oncolytic virus immunotherapy platform to treat cancer and bluebird bio as the Sr. Director of Technical Operations and head of Cellular Process Development and Manufacturing Operations for all lentiviral vector-based autologous hematopoietic stem cell and CAR T cell programs.
Michael received his Bachelor of Science degree from Providence College and his Masters in Biochemistry and Molecular Biology from the University of New Hampshire.